It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Carbon-negative synthesis of biochemical products has the potential to mitigate global CO2 emissions. An attractive route to do this is the reverse β-oxidation (r-BOX) pathway coupled to the Wood-Ljungdahl pathway. Here, we optimize and implement r-BOX for the synthesis of C4-C6 acids and alcohols. With a high-throughput in vitro prototyping workflow, we screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity. Implementation of these pathways into Escherichia coli generates designer strains for the selective production of butanoic acid (4.9 ± 0.1 gL−1), as well as hexanoic acid (3.06 ± 0.03 gL−1) and 1-hexanol (1.0 ± 0.1 gL−1) at the best performance reported to date in this bacterium. We also generate Clostridium autoethanogenum strains able to produce 1-hexanol from syngas, achieving a titer of 0.26 gL−1 in a 1.5 L continuous fermentation. Our strategy enables optimization of r-BOX derived products for biomanufacturing and industrial biotechnology.
An attractive route for carbon-negative synthesis of biochemical products is the reverse β-oxidation pathway coupled to the Wood-Ljungdahl pathway. Here the authors use a high-throughput in vitro prototyping workflow to screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 Northwestern University, Department of Chemical and Biological Engineering and Center for Synthetic Biology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
2 LanzaTech Inc., Skokie, USA (GRID:grid.16753.36)
3 University of South Florida, Department of Chemical, Biological, and Materials Engineering, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X)
4 LanzaTech Inc., Skokie, USA (GRID:grid.170693.a); University of South Florida, Department of Chemical, Biological, and Materials Engineering, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X)
5 LanzaTech Inc., Skokie, USA (GRID:grid.170693.a)
6 Northwestern University, Department of Biomedical Engineering, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Chemistry, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
7 Northwestern University, Department of Chemical and Biological Engineering and Center for Synthetic Biology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Biomedical Engineering, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Chemistry, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)